Cartography
Cartography Biosciences is creating therapeutics guided by the first comprehensive antigen atlas for immuno-oncology targets.
Challenge
How do you introduce the company building a therapeutic pipeline against best-in-class targets to enable immunotherapies to reach their full potential and unleash profound therapeutic opportunities for patients?
Approach
Cartography Biosciences is a precision medicine company creating therapeutics guided by the first-ever comprehensive antigen atlas for immuno-oncology targets.
In July 2022, we helped launch the company and announce a Series A round led by 8VC with strong participation from existing investors Andreessen Horowitz, which led Cartography’s seed financing, and Wing VC, which was also a seed investor. The Series A financing was joined by new investors Catalio Capital Management, ARTIS Ventures, Alexandria Venture Investments, AME Cloud Ventures, the Cancer Research Institute, and Gaingels.
The work entailed a brand refresh including redesigned logo, new website, messaging and positioning, social media content and deployment strategy, and an embargoed press release and media relations campaign.
Impact
The media coverage of Cartography’s Series A engaged more than 10 million and included featured articles in tier 1 trade outlets such as Endpoints News, FierceBiotech, Chemical & Engineering News, BioCentury, and national business outlets including WSJ Venture Pro, Fortune, and Axios.
Audiences were made aware of the company’s plans to use the Series A proceeds to advance a pipeline of therapeutics designed to broaden the reach of next-generation cancer therapies, as well as conduct a breadth of discovery programs designed to identify novel, best-in-class target antigens across a range of cancer indications..
“Immunotherapies can only be as effective as the antigens they target. In order to bring the tremendous potential of immunotherapy to otherwise untreatable cancers, we first need to identify precise antigen targets for those cancers.”
Kevin Parker – Co-founder and CEO of Cartography
Series A
